Wolverine Trading’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $25M | Buy |
451,000
+69,800
| +18% | +$4.09M | 0.02% | 511 |
|
|
2025
Q2 | $26.1M | Buy |
381,200
+62,000
| +19% | +$4.22M | 0.03% | 388 |
|
|
2025
Q1 | $22.1M | Buy |
319,200
+163,600
| +105% | +$13.5M | 0.03% | 386 |
|
|
2024
Q4 | $13.3M | Sell |
155,600
-60,400
| -28% | -$6.53M | 0.01% | 647 |
|
|
2024
Q3 | $26.1M | Buy |
216,000
+58,900
| +37% | +$7.86M | 0.03% | 347 |
|
|
2024
Q2 | $22.4M | Sell |
157,100
-900
| -0.6% | -$119K | 0.02% | 358 |
|
|
2024
Q1 | $20.3M | Buy |
158,000
+39,800
| +34% | +$4.74M | 0.02% | 413 |
|
|
2023
Q4 | $12.2M | Sell |
118,200
-57,800
| -33% | -$5.72M | 0.01% | 632 |
|
|
2023
Q3 | $16M | Buy |
176,000
+71,800
| +69% | +$6.32M | 0.02% | 458 |
|
|
2023
Q2 | $8.18M | Buy |
104,200
+73,600
| +241% | +$6.01M | 0.01% | 674 |
|
|
2023
Q1 | $2.42M | Sell |
30,600
-56,800
| -65% | -$4.03M | ﹤0.01% | 1249 |
|
|
2022
Q4 | $5.91M | Buy |
87,400
+64,800
| +287% | +$3.8M | 0.01% | 809 |
|
|
2022
Q3 | $1.13M | Buy |
+22,600
| New | +$1.21M | ﹤0.01% | 1843 |
|
|
2022
Q2 | – | Sell |
-12,000
| Closed | -$675K | – | 5341 |
|
|
2022
Q1 | $675K | Sell |
12,000
-28,200
| -70% | -$1.45M | ﹤0.01% | 2881 |
|
|
2021
Q4 | $2.24M | Buy |
40,200
+11,400
| +40% | +$618K | ﹤0.01% | 1784 |
|
|
2021
Q3 | $1.38M | Buy |
28,800
+19,400
| +206% | +$938K | ﹤0.01% | 2579 |
|
|
2021
Q2 | $394K | Hold |
9,400
| – | – | ﹤0.01% | 4043 |
|
|
2021
Q1 | $319K | Buy |
+9,400
| New | +$335K | ﹤0.01% | 4386 |
|
|
2020
Q3 | – | Sell |
-43,800
| Closed | -$1.44M | – | 4951 |
|
|
2020
Q2 | $1.44M | Buy |
+43,800
| New | +$1.4M | ﹤0.01% | 1667 |
|
|
2020
Q1 | – | Sell |
-83,200
| Closed | -$2.4M | – | 5069 |
|
|
2019
Q4 | $2.4M | Sell |
83,200
-2,800
| -3% | -$77.5K | 0.01% | 1689 |
|
|
2019
Q3 | $2.22M | Buy |
86,000
+26,600
| +45% | +$673K | 0.01% | 1369 |
|
|
2019
Q2 | $1.52M | Buy |
59,400
+6,800
| +13% | +$168K | ﹤0.01% | 1703 |
|
|
2019
Q1 | $1.38M | Sell |
52,600
-35,200
| -40% | -$865K | ﹤0.01% | 1809 |
|
|
2018
Q4 | $2.01M | Buy |
87,800
+10,400
| +13% | +$231K | 0.01% | 1410 |
|
|
2018
Q3 | $1.82M | Buy |
77,400
+35,400
| +84% | +$864K | ﹤0.01% | 1753 |
|
|
2018
Q2 | $1.03M | Hold |
42,000
| – | – | ﹤0.01% | 2240 |
|
|
2018
Q1 | $1.03M | Buy |
+42,000
| New | +$1.1M | ﹤0.01% | 2240 |
|
|
2017
Q4 | – | Sell |
-34,000
| Closed | -$819K | – | 5308 |
|
|
2017
Q3 | $819K | Buy |
34,000
+10,400
| +44% | +$235K | ﹤0.01% | 2085 |
|
|
2017
Q2 | $500K | Sell |
23,600
-24,400
| -51% | -$492K | ﹤0.01% | 2433 |
|
|
2017
Q1 | $811K | Sell |
48,000
-14,400
| -23% | -$251K | ﹤0.01% | 1902 |
|
|
2016
Q4 | $1.12M | Sell |
62,400
-12,600
| -17% | -$228K | 0.01% | 1809 |
|
|
2016
Q3 | $1.57M | Buy |
+75,000
| New | +$1.86M | 0.01% | 1478 |
|
Other funds holding NVO
F
Wolverine Trading's NVO Position: Q3 2025 in Review
Wolverine Trading reduced its Novo Nordisk (NVO) stake by 85% in Q3 2025, selling an estimated $3.24M and leaving 9,629 shares worth $534K. The position accounts for ﹤0.01% of the portfolio, ranked #3633.
Wolverine Trading first reported a position in NVO in Q1 2017 and has held it in 25 quarters since. The position peaked at $10.7M in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.
- Wolverine Trading held 9,629 shares of Novo Nordisk worth $534K as of Q3 2025.
- Wolverine Trading sold 55,416 Novo Nordisk shares in Q3 2025, an estimated $3.24M.
- Novo Nordisk made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3633 holding.
- Wolverine Trading first reported a position in Novo Nordisk in Q1 2017 and has held it in 25 quarters since.
- Wolverine Trading's Novo Nordisk position peaked at $10.7M in Q2 2024.
- 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.